New Funding Led by Moderna, Bayer, Brings Metagenomi's Series B to $275M

Metagenomi is kicking off the new year the way we all wish we were - with an extra $100 million. The biotech scored the cash in a Series B extension financing round announced Thursday, bringing its total Series B to $275 million.

The financing round was led by Leaps by Bayer, Moderna and several others, signaling that Metagenomi’s efforts in 2022 did not go unnoticed by its big pharma peers.